Antigen Cross-Presentation by Macrophages [PDF]
The contribution of dendritic cell (DC) antigen cross-presentation to the activation of CD8+ T lymphocytes for immune defense against tumors, viruses, and intracellular pathogens has been recognized widely.
Elke M. Muntjewerff +3 more
doaj +12 more sources
Current Concepts of Antigen Cross-Presentation [PDF]
Dendritic cells have the ability to efficiently present internalized antigens on major histocompatibility complex (MHC) I molecules. This process is termed cross-presentation and is important role in the generation of an immune response against viruses ...
Maria Embgenbroich, Sven Burgdorf
doaj +9 more sources
Antigen cross-presentation of immune complexes [PDF]
The ability of dendritic cells (DC) to cross-present tumor antigens has long been a focus of interest of physicians, as well as basic scientists, that aim to establish efficient cell-based cancer immune therapy. A prerequisite for exploiting this pathway
Barbara ePlatzer +2 more
doaj +9 more sources
Regulation of Antigen Export to the Cytosol During Cross-Presentation [PDF]
Cross-priming refers to the induction of primary cytotoxic CD8+ T cell responses to antigens that are not expressed in antigen presenting cells (APCs) responsible for T cell priming.
Marine Gros, Sebastian Amigorena
doaj +7 more sources
The Role of Heat Shock Proteins in Antigen Cross Presentation [PDF]
Heat shock proteins (HSP) are molecular chaperones that can bind tumor antigens (Ag) and mediate their uptake into antigen presenting cells (APC). HSP-antigen complexes are then directed towards the MHC class I pathway through antigen cross presentation ...
Ayesha eMurshid +2 more
doaj +7 more sources
MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy [PDF]
Nanoparticles made of the coat protein of papaya mosaic virus (PapMV) and a single-strand RNA were previously shown to be an efficient antigen presentation system for the trigger of cellular immunity.
David Possamaï +8 more
doaj +3 more sources
Tumor‐Derived CDC37 Inhibits Antigen Cross‐Presentation in Dendritic Cells and Impairs Anti‐Tumor Immunity in Breast Cancer [PDF]
Tumor mutational burden (TMB), usually representing high immunogenicity, cannot always predict treatment response of immune checkpoint blockade (ICB).
Ruxin Wang +10 more
doaj +2 more sources
Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis enhances antigen cross-presentation and antitumor efficacy through ROS production [PDF]
IntroductionLactococcus lactis (L.L) is safe and can be used as vehicle. In this study, the immunoregulatory effect of L.L on dendritic cell (DC) activation and mechanism were investigated. The immune responses and antigen cross-presentation mechanism of
Tingting Zhang +7 more
doaj +2 more sources
ERα blockade in dendritic cells enhances antigen cross-presentation and induces antitumor CD8+ T cell immunity [PDF]
Dendritic cells (DC) dysfunction impedes antitumor immunity, so understanding intrinsic regulators of DC antigen presentation and the resulting activation of antitumor CD8+ T cells could benefit therapy.
Yaxin Liu +12 more
doaj +2 more sources
Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells. [PDF]
CD8 T cells are the predominant effector cells of adaptive immunity in preventing cytomegalovirus (CMV) multiple-organ disease caused by cytopathogenic tissue infection.
Stefan Ebert +7 more
doaj +2 more sources

